Literature DB >> 25952961

Association of LRRK2 and GBA mutations in a Brazilian family with Parkinson's disease.

Mariana Spitz1, João Santos Pereira2, Denise Hack Nicareta3, Gabriella de Medeiros Abreu4, Elenice Ferreira Bastos5, Taís Leite Seixas6, Márcia Mattos Gonçalves Pimentel4.   

Abstract

Entities:  

Keywords:  G2019S; GBA; Genetics; L444P; LRRK2; Parkinson's disease

Mesh：

Substances：

Year:  2015        PMID： 25952961     DOI： 10.1016/j.parkreldis.2015.03.029

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN： 1353-8020            Impact factor:   4.891


× No keyword cloud information.
  4 in total

1.  LRRK2 kinase activity regulates lysosomal glucocerebrosidase in neurons derived from Parkinson's disease patients.

Authors:  Daniel Ysselstein; Maria Nguyen; Tiffany J Young; Alex Severino; Michael Schwake; Kalpana Merchant; Dimitri Krainc
Journal:  Nat Commun       Date:  2019-12-05       Impact factor: 14.919

2.  Urinary proteome profiling for stratifying patients with familial Parkinson's disease.

Authors:  Sebastian Virreira Winter; Ozge Karayel; Maximilian T Strauss; Shalini Padmanabhan; Matthew Surface; Kalpana Merchant; Roy N Alcalay; Matthias Mann
Journal:  EMBO Mol Med       Date:  2021-01-22       Impact factor: 12.137

3.  Resequencing analysis of five Mendelian genes and the top genes from genome-wide association studies in Parkinson's Disease.

Authors:  Bruno A Benitez; Albert A Davis; Sheng Chih Jin; Laura Ibanez; Sara Ortega-Cubero; Pau Pastor; Jiyoon Choi; Breanna Cooper; Joel S Perlmutter; Carlos Cruchaga
Journal:  Mol Neurodegener       Date:  2016-04-19       Impact factor: 14.195

4.  Identification of sixteen novel candidate genes for late onset Parkinson's disease.

Authors:  Alessandro Gialluisi; Mafalda Giovanna Reccia; Nicola Modugno; Teresa Nutile; Alessia Lombardi; Luca Giovanni Di Giovannantonio; Sara Pietracupa; Daniela Ruggiero; Simona Scala; Stefano Gambardella; Licia Iacoviello; Fernando Gianfrancesco; Dario Acampora; Maurizio D'Esposito; Antonio Simeone; Marina Ciullo; Teresa Esposito
Journal:  Mol Neurodegener       Date:  2021-06-21       Impact factor: 14.195
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.